Avicanna Inc. AVCNF AVCN 0NN has expanded its R&D collaboration with Bio-Gate AG with a 5-year exclusive distribution agreement for Pura H&W branded CBD derma-cosmetics.
Avicanna and Bio-Gate are expanding their existing research collaboration with the commercial distribution of Avicanna’s evidence-based derma-cosmetic line Pura H&W into the European market.
The initial focus of the launch is the German-speaking regions of the continent including Germany, Austria and Switzerland where Bio-Gate has an established distribution network of pharmacies and retail channels.
In addition, Bio-Gate has the right to select 3 additional European countries for exclusive distribution within the first 12 months of the agreement.
“We are very pleased to launch the Pura H&W product line from Avicanna, a leader in the cannabidiol market, in the European market. We are convinced that the Pura product line is an ideal extension to our product portfolio for our dermatology division. We are looking forward to a successful cooperation,” stated Marc Lloret-Grau, CEO of Bio-Gate AG.
The derma-cosmetic products are registered at the cosmetic products notification portal which allows them to be commercialized over the counter as cosmetic products in every jurisdiction within the European Union.
Three cosmetic clinical studies were completed on Avicanna’s Pura H&W formulations targeting cosmetic factors associated with aging, acne-prone skin, and eczema-prone skin. The successfully completed studies involved 156 patients that were tested for safety and specific derma-cosmetic endpoints, including hydration and excess oil production. All three studies achieved positive results in the endpoints with no adverse effects.
Aras Azadian CEO of Avicanna, will be one of the many amazing speakers at the Benzinga Cannabis Capital Conference in Miami. There’s still time to sign up for the event that will host many top names in the cannabis industry. Click here for more info.
Related News
Avicanna Closes $2M Non-Brokered Private Placement
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Avicanna Provides Q4-2021 Results And Fiscal 2022 Guidance
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.